secwatch.observer — SEC 8-K summary
======================================

Issuer:     INTEGRA LIFESCIENCES HOLDINGS CORP (IART)
CIK:        0000917520
Form:       8-K
Filed at:   2026-05-08T23:59:59+00:00
Accession:  0000917520-26-000044
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Integra LifeSciences shareholders approve 3.55M share increase to equity incentive plan
--------------------------------------------------------------------------------

- Shareholders approved Amendment No. 3 to increase shares available under the plan by 3,550,000 to 24,250,000 total shares.
- All 7 director nominees were elected; Barbara B. Hill received the most votes against (7,042,475).
- Ratification of PricewaterhouseCoopers as 2026 auditor passed with 72,313,820 votes for.
- Advisory say-on-pay approved with 68,472,769 votes for.
- Equity plan amendment received 68,005,433 votes for and 1,269,231 against.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/917520/000091752026000044/0000917520-26-000044-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/917520/000091752026000044/iart-20260507.htm
  HTML page:      https://secwatch.observer/filing/0000917520-26-000044

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer